REGN

Regeneron Pharmaceuticals, Inc. News Headlines

$413.04
*  
0.535
0.13%
Get REGN Alerts
*Delayed - data as of Mar. 4, 2015  -  Find a broker to begin trading REGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Regeneron Pharmaceuticals (REGN) Jumps: Stock Up 8.5% - Tale of the Tape
10/20/2014 8:39:00 AM - Zacks.com


Cramer's Lightning Round - Ensco Is One Of The Worst Stocks I've Owned In My Life (10/17/14)
10/19/2014 6:24:00 AM - Seeking Alpha


InsiderInsights.com Daily Round Up 10/17/14: REGN, KEY, ALSN, AGCO
10/18/2014 9:55:00 AM - Seeking Alpha


Pharmacyclics, Roche Ink Deal for Cancer Combo Therapy - Analyst Blog
10/17/2014 5:15:00 PM - Zacks.com


Friday's ETF Movers: BBH, GDX
10/17/2014 1:39:46 PM - BNK Invest


S&P 500 Analyst Moves: REGN
10/17/2014 1:38:20 PM - BNK Invest


Nasdaq 100 Movers: NFLX, XLNX
10/17/2014 11:37:49 AM - BNK Invest


Cramer's Lightning Round - You Get Good News From Regeneron (10/16/14)
10/17/2014 6:08:00 AM - Seeking Alpha


Ohr Pharmaceutical's OHR-102 to Enter Phase III in 1H15 - Analyst Blog
10/16/2014 6:00:00 PM - Zacks.com


Bristol-Myers Collaborates for Opdivo-Imbruvica Combo - Analyst Blog
10/14/2014 4:20:00 PM - Zacks.com


Celgene's Otezla Encourages in Plaque Psoriasis at EADV - Analyst Blog
10/13/2014 4:19:00 PM - Zacks.com


Ohr Pharamceuticals: Stay On The Sidelines
10/10/2014 7:45:00 AM - Seeking Alpha


Portfolio Changes For The Third Quarter 2014
10/9/2014 9:14:00 AM - Seeking Alpha


Bristol-Myers Gives Up on US Approval of 2-Drug HCV Combo - Analyst Blog
10/8/2014 5:10:00 PM - Zacks.com


Amgen's Data on Evolocumab Published in The Lancet - Analyst Blog
10/8/2014 10:20:00 AM - Zacks.com


Biotech Stock Roundup: Sunesis Tanks on Study Results, Chimerix Up on Ebola Update - Analyst Blog
10/8/2014 7:14:00 AM - Zacks.com


Regeneron's Eye Drug Eylea Wins Another FDA Approval - Analyst Blog
10/7/2014 3:30:00 PM - Zacks.com


Rexahn's New Nanotechnology Patent Creates Next-Generation Docetaxel, Gemcitabine And Cisplatin
10/7/2014 10:01:00 AM - Seeking Alpha


Should Pfizer Inc. Buy This Surprisingly Competitive Biotech Stock?
10/7/2014 7:30:16 AM - Motley Fool


Overdue Market Weakness Finally Hits, But Sector Rankings Turn Bullish
10/6/2014 3:35:00 PM - Seeking Alpha


Regeneron Pharmaceuticals Has A Bright Future Ahead
10/6/2014 10:49:00 AM - Seeking Alpha


Regeneron-Sanofi's Dupilumab Meets All Endpoints - Analyst Blog
10/3/2014 2:00:00 PM - Zacks.com


Sector Update: Health-Care Shares Mixed Pre-Market
10/1/2014 7:22:19 AM - MT Newswires


Sector Update: Health Care
10/1/2014 7:18:07 AM - MT Newswires


Cramer's Mad Money - Stop Worrying About The Death Cross (9/30/14)
10/1/2014 5:59:00 AM - Seeking Alpha